Seeking Alpha

MITI

Micromet, Inc.

5/26/2012, 4:50 PM ET

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

228 people get MITI articles and Market Currents by email alert.

Get email alerts on MITI »

MITI Market Currents more »

January 26 Micromet (MITI) surges 34% to $11.07, which is just above Amgen's (AMGN) $11/share offer for the company.
1 Comment
[Healthcare, Top Stories, M&A]

MITI in Focus more »

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Ohad Hammer • Sun, Oct 16, 2011 • 14 Comments
Micromet Balances Risk And Reward

Zacks Investment Research • Mon, Sep 12, 2011 • Comment!
The Sky's the Limit for Micromet's BiTE Technology

Prohost Biotech • Thu, Jul 14, 2011 • 6 Comments
Micromet Leads in Bispecific Antibodies

Jason Chew • Wed, May 11, 2011 • 5 Comments
Micromet, Inc. Q1 2010 Earnings Call Transcript

Wed, May 5, 2010 • Comment!

MITI Related Articles more »

Breaking The Mold Of Oncology Drug Development

Brian Nichols • Tue, Apr 10 • 6 Comments
Upgrades Lead To Optimism In Cancer Stem Cell Therapy

Brian Nichols • Tue, Mar 13 • 9 Comments
Threshold Scores Big With Pancreatic Cancer Data

Ohad Hammer • Mon, Mar 5 • 5 Comments
Dendreon's Woes Mask The Exciting Opportunities In Immunotherapy Companies

Brian Nichols • Thu, Mar 1 • 57 Comments
4 Outperforming Biotech Stocks with Bullish Short Trends

Kapitall • Wed, Feb 29 • 4 Comments
7 Low Risk, Low Debt Stocks With Short Covering

Kapitall • Thu, Feb 23 • Comment!
Buy Biotech In Phase II For The Best Upside

Brian Nichols • Wed, Feb 22 • 5 Comments
February's Merger Arbitrage Option Plays

Value Research • Tue, Feb 7 • 2 Comments
Diversifying Your Portfolio With Biotechnology Stocks

Brian Nichols • Mon, Feb 6 • 14 Comments
3 M&A Arbitrage Opportunities

The Financial Lexicon • Sun, Feb 5 • 2 Comments

MITI News more »

Increased Merger Activity Expected This Year

at CNBC.com (Feb 24, 2012)
Stocks End Lower as Fed Optimism Fizzles

at CNBC.com (Jan 26, 2012)
Futures Hold Gains After Economic Reports

at CNBC.com (Jan 26, 2012)
Biotech Stocks: Sanofi, Bayer lead drug-stocks slide

at MarketWatch.com (Jul 11, 2011)
Biotech Stocks: Drug stocks follow broader market south

at MarketWatch.com (Jun 10, 2011)

MITI Press Releases and Filings more »

Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab

Business Wire (Jan 9, 2012)
Micromet’s Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Business Wire (Dec 12, 2011)
Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients

Business Wire (Dec 11, 2011)
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer

Business Wire (Dec 5, 2011)

MITI Latest Transcript more »

Micromet, Inc. Q1 2010 Earnings Call Transcript

Wed, May 5, 2010
Popular searches: mark, actually, obviously, u.s, now, itin, look, year, blinatumomab, miti.

Earlier MITI transcripts

MITI Cramer more »

Cramer's Mad Money - 6 Things to Watch in the Coming Week (4/1/11)

Sun, Apr 3, 2011

MITI Instablog posts more »

Barchart Morning Call 3/2

Fri, Mar 2 • Jim Van Meerten • Comment!
Investing In Innovative Human Therapeutics Called Biotech

Mon, Feb 27 • Michael Michaud • Comment!
Personalized Medicine for the Masses

Tue, May 24, 2011 • Philip Davis • Comment!
Stock World Weekly: No Easy Way Out

Sun, May 22, 2011 • Philip Davis • 1 Comment
No Easy Way Out

Sun, May 22, 2011 • Ilene at PSW • Comment!

Write a post on MITI

MITI StockTalks

MITI vs. ETF Alternatives

Company Description

Currently, there's no company description for MITI.

Sector: Healthcare

Industry: Biotechnology

Country: United States